Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis
- 1 October 1997
- Vol. 15 (15) , 1652-1660
- https://doi.org/10.1016/s0264-410x(97)00083-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies in Catalonia, SpainPharmacoEconomics, 1995
- Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedulesVaccine, 1990
- LOW-DOSE HEPATITIS B VACCINEThe Lancet, 1989
- Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on ImmunizationClinical Infectious Diseases, 1989
- The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmesEpidemiology and Infection, 1988
- Efficacy of Hepatitis B VaccineOccupational Medicine, 1988
- Cost-effectiveness of prenatal screening and immunization for hepatitis B virusJAMA, 1988
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985
- Indications for Use of Hepatitis B Vaccine, Based on Cost-Effectiveness AnalysisNew England Journal of Medicine, 1982
- NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERSThe Lancet, 1981